According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 107,415,000. At the end of 2023 the company had 107,415,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.10 B | 1.3% |
2022 | 0.10 B | 1.44% |
2021 | 0.10 B | 1.73% |
2020 | 0.10 B | 5.84% |
2019 | 97.09 M | 6.58% |
2018 | 91.09 M | 21.73% |
2017 | 74.83 M | 4.74% |
2016 | 71.44 M | 19.98% |
2015 | 59.54 M | 8.88% |
2014 | 54.69 M | 44.91% |
2013 | 37.74 M | 167.41% |
2012 | 14.11 M | 39.45% |
2011 | 10.12 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 2,141.03% | ๐บ๐ธ USA |
Moderna
MRNA | 381,000,000 | 254.70% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | 17,380,000 | -83.82% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | 73,916,400 | -31.19% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | 125,220,000 | 16.58% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | 22,385,229 | -79.16% | ๐บ๐ธ USA |